Using PET to stage patients with limited-stage small-cell lung cancer before treatment improves survival rate.
Patients with limited-stage small-cell lung cancer (LS-SCLC) who undergo pretreatment staging with PET showed better disease control and survival, according to a study published in the Journal of Thoracic Oncology.
In 2012, the National Comprehensive Cancer Network (NCCN) recommended that newly diagnosed patients with SCLC undergo a PET-CT, a change from their previous recommendation of a bone scan. Researchers from the University of Pennsylvania undertook a study to determine the clinical impact of the new recommendation.
Fifty-four patients with LS-SCLC who underwent concurrent chemoradiation from January 2001 to August 2010 were identified for the study. The researchers looked at the patients’ scanning history and treatment outcomes. All patients underwent thoracoabdominopelvic CT and MRI neuroimaging. Forty patients underwent PET.
The results showed that more patients who underwent PET staging presented with nodal metastases. The median overall survival from diagnosis in the patients who underwent PET before treatment was 32 months versus 17 months in patients staged without PET. Three-year survival was 47 percent (PET) versus 19 percent (non-PET).
“Pretreatment PET staging of LS-SCLC was associated with improved survival,” the authors wrote. “PET-staged patients had an improved three-year overall survival from diagnosis compared with those with LS-SCLC who were not staged with PET.”
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.